Serum insulin-like growth factor 1 and growth hormone levels of hypoxic-ischemic newborns

Biology of the Neonate

Volumn 85, Issue 1, 2004, Pages 15-20

  Satar, Mehmet ^a   Özcan, Kenan ^a   Yapicioǧlu, Hacer ^a   Narli, Nejat ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Growth hormone; Hypoxic ischemic encephalopathy; Insulin like growth factor 1

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CIRCULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MALE; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

BLOOD GLUCOSE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 1842562200     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074952     Document Type: Article

References (34)

1. Gomella TL: Perinatal asphyxia; in Gomella TL (ed): Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs, ed 4. Stamford, Appleton & Lange, 1999, pp 480-490.
2. Hill A, Volpe JJ: Hypoxic-ischemic cerebral injury in the newborn; in Swaimann KF (ed): Pediatric Neurology, ed 2. St. Louis, Mosby, 1994, pp 489-508.
3. Finer NN, Robertson CM, Richards RT: Hypoxic-ischemic encephalopathy in term neonates: Perinatal factors and outcome. J Pediatr 1981;98:112-117.
4. Beilharz EJ, Klempt ND, Klempt M, Sirimanne E, Dragunow M, Gluckman PD: Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res Mol Brain Res 1993;18:209-215.
5. Gluckman PD, Klempt ND, Guan J, Mallard EC, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams CE, Nikolics K: A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992;182:593-599.
6. Lorez HP, Keller F, Ruess G, Otten U: Nerve growth factor increases in adult rat brain after hypoxic injury. Neurosci Lett 1989;98:339-344.
7. Bergstedt K, Wieloch T: Changes in insulin-like growth factor 1 receptor density after transient cerebral ischemia in the rat: Lack of protection against ischemic brain damage following injection of insulin-like growth factor 1. J Cereb Blood Flow Metab 1993;13:895-898.
8. Johnston BM, Mallard EC, Williams CE, Gluckman PD: Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest 1996;97:300-308.
9. Sizonenko SV, Sirimanne ES, Williams CE, Gluckman PD: Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury. Brain Res 2001;922:42-50.
10. Daughaday WA, Rotwein P: Insulin-like growth factors I and II: Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 1989;10:68-91.
11. Sara VR, Carlsson-Skwirut C: The role of the insulin-like growth factors in the regulation of brain development. Prog Brain Res 1988;73:87-99.
12. Schwab S, Spranger M, Krempien S, Hacke W, Bettendorf M: Plasma insulin-like growth factor I and IGF-binding protein 3 levels in patients with acute cerebral ischemic injury. Stroke 1997;28:1744-1748.
13. Scott MG, Cuca GC, Petersen JR, Lyle LR, Burleigh BD, Daughaday WH: Specific immunoradiometric assay of insulin-like growth factor I with use of monoclonal antibodies. Clin Chem 1987;33:2019-2023.
14. Baxter RC: Insulin-like growth factor (IGF) binding proteins: Interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000;278:E967-E976.
15. Mueller RW, Hunt TK, Tokunaga A, Spencer EM: The effect of insulin-like growth factor I on wound healing variables and macrophages in rats. Arch Surg 1994;129:262-265.
16. Rotwein P, Burgess JD, Milbrandt JD, Krause JE: Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci U S A 1988;85:265-268.
17. Sara V, Hall K, von Holtz H, Humbel R, Sjörgen B, Wetterberg L: Evidence for the presence of receptors for insulin-like growth factors 1 (IGF-1) and 2 (IGF-2) and insulin throughout the adult human brain. Neurosci Lett 1982;34:39-44.
18. Bohannon NJ, Corp ES, Wilcox BJ, Figlewicz DP, Dorsa DM, Baskin DG: Localization of binding sites for insulin-like growth factor I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res 1988;444:205-213.
19. Knüsel B, Michel PP, Schwaber JS, Hefti F: Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors 1 and 2. J Neurosci 1990;10:558-570.
20. Kanje M, Skottner A, Sjöberg J, Lundborg G: Insulin-like growth factor 1 (IGF-1) stimulates regeneration of sciatic rat nerve. Brain Res 1989;486:396-398.
21. Scheepens A, Sirimanne E, Beilharz E, Breier BH, Waters MJ, Gluckman PD, Williams CE: Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury. Brain Res Mol Brain Res 1999;68:88-100.
22. Gustafson K, Hagberg H, Bengtsson B, Brantsing C, Isgaard J: Possible protective role of growth hormone in hypoxia-ischemia in neonatal rats. Pediatr Res 1999;45:318-323.
23. Reinhardt RR, Bondy CA: Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994;135:1753-1761.
24. Guan J, Skinner SJ, Beilharz EJ, Hua KM, Hodgkinson S, Gluckman PD, Williams CE: The movement of IGF-I into the brain parenchyma after hypoxic-ischaemic injury. Neuroreport 1996;7:632-636.
25. Beilharz EJ, Russo VC, Butler G, Baker NL, Connor B, Sirimanne ES, Dragunow M, Werther GA, Gluckman PD, Williams CE, Scheepens A: Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res 1998;59:119-134.
26. Baxter RC, Hawker FH, To C, Stewart RM, Holman SR: Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Horm IGF Res 1998;8:455-463.
27. Varvarigou A, Vagenakis AG, Makri M, Frimas C, Beratis NG: Prolactin and growth hormone in perinatal asphyxia. Biol Neonate 1996;69:76-83.
28. Gelato MC: The growth hormone/insulin-like growth factor axis in critical illness. J Pediatr Endocrinol Metab 2000;13:1023-1029.
29. Frost RA, Lang CH, Gelato MC: Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 1997;138:4153-4159.
30. Frost RA, Lang CH, Gelato MC: Growth hormone/insulin-like growth factor axis in human immunodeficiency virus-associated disease. Endocrinologist 1997;7:23-31.
31. Szaflarski J, Burtrum D, Silverstein FS: Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995;26:1093-100.
32. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Bennow M, Holst M, McRae A, Soder O: Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996;40:603-609.
33. Oygur N, Sonmez O, Saka O, Yegin O: Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 1998;79:F190-F193.
34. Foster-Barber A, Dickens B, Ferriero DM: Human perinatal asphyxia: Correlation of neonatal cytokines with MRI and outcome. Dev Neurosci 2001;23:213-218.